Pharmafile Logo
Pharmafocus logo
Advanced Search

Cancer

Showing 15 posts of 1067 posts found.

screen_shot_2012-06-06_at_10

William Kaelin Jr elected to Lilly board

June 6, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Cancer, Kaelin, lilly

Eli Lilly has elected William Kaelin Jr to its board of directors. Dr Kaelin, 54, is a Professor in the Department of …

Appointment
ASCO

Herceptin successor impresses at ASCO

June 6, 2012
Research and Development, Sales and Marketing ASCO, Cancer, EMILIA, FDA, Roche, T-DM1

Roche’s new ‘smart bomb’ breast cancer drug T-DM1 has impressed at this year’s ASCO conference in Chicago. The trial showed it …

News

Cancer Drugs Fund ‘the wrong choice’ for Wales

May 29, 2012
Sales and Marketing CDF, Cancer, NHS, Wales, Welsh

The Welsh health minister Lesley Griffiths has said that a Cancer Drugs Fund is ‘not the right course’ for Wales. …

News
yervoy image

Scottish watchdog rejects Yervoy

May 14, 2012
Sales and Marketing BMS, Cancer, NICE, SMC, Yervoy, melanoma

The Scottish Medicines Consortium is not recommending Bristol-Myers Squibb’s melanoma treatment Yervoy.  The SMC said that Yervoy (ipilimumab), which has …

News
Coughing woman image

UK government launches lung cancer awareness campaign

May 8, 2012
Medical Communications Cancer, UK, government, lung

The UK government has launched a new lung cancer awareness campaign backed by a number of celebrities.  Ricky Gervais and …

News
GSK picture

GSK signs deal with academics

May 4, 2012
Research and Development, Sales and Marketing Cancer, GSK, PROTAC, Yale, academia

GlaxoSmithKline has forged another link with academia, signing a deal with Yale University to design a potential new class of …

News
Votrient image

FDA approves GSK’s Votrient for new licence

April 30, 2012
Sales and Marketing Cancer, FDA Approval, GSK, Votrient

The FDA has approved GlaxoSmithKline’s cancer pill Votrient for the treatment of a rare group of cancers – but has …

News
Herceptin image

New data shows Herceptin’s ability to increase survival

April 24, 2012
Research and Development, Sales and Marketing Cancer, Cochrane, Herceptin, Roche, breast

A new review of Roche’s breast cancer drug Herceptin has confirmed its ability to increase overall survival, but concerns remain …

News

Government to speed up access to new cancer drugs

April 24, 2012
Sales and Marketing CDF, Cancer, Roche, UK, avastin, government, sha

Access to England’s Cancer Drugs Fund will be speeded up, ministers have confirmed.  Currently, it can take a number of …

News
Merck image

Merck does cancer drug deal with Endocyte

April 17, 2012
Research and Development, Sales and Marketing Cancer, Endocyte, Merck, NSCLC, vintafolide

Merck is to pay $120 million to US biopharma company Endocyte as part of a deal to develop and commercialise …

News

UK government invests in new radiotherapy treatment

April 16, 2012
Sales and Marketing Cancer, Photon beam therapy, Proton beam therapy, prostate cancer, radiotherapy

The government is to invest £250 million in a cutting-edge radiotherapy treatment that should benefit 1,500 cancer patients in the …

News

Access to new cancer drugs limited in Brazil and Mexico

April 13, 2012
Sales and Marketing Brazil, Cancer, Mexico, avastin, emerging markets

Between one-quarter and one-third of patients in Brazil and Mexico who are eligible for treatment with new cancer drugs do …

News
Bayer image

Bayer cancer drug meets Phase III goal

April 3, 2012
Research and Development, Sales and Marketing Bayer, Cancer, Glivec, Novartis, phase III, regorafenib

Bayer’s stomach cancer pill regorafenib has significantly improved progression free survival in late-stage patients. Results from the Phase III trial …

News

Photodynamic treatment for HPV shows potential

March 15, 2012
Research and Development Cancer, GE Healthcare, HPV, Photocure, ipsen, oncologly

A new photodynamic therapy treatment for human papilloma virus (HPV) associated diseases of the cervix has shown potential in a …

News
Zelboraf image

European approval for Roche’s Zelboraf

February 20, 2012
Sales and Marketing Cancer, Roche, Yervoy, Zelboraf, melanoma

Roche’s skin cancer pill Zelboraf has been given European approval to treat advanced melanoma.  Zelboraf (vemurafenib) is now available in …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026